In addition, altered levels of hepatokines such as fetuin-A, fibroblast growth factor 21, and selenoprotein P in NAFLD might directly affect the progression of atherosclerosis by modulating endothelial dysfunction and infiltration of inflammatory cells into vessel walls. Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.